β Amyloid 1-40 ELISA human

sufficient for 96 multiwell tests

Amyloid β ELISA, β Amyloid ELISA
Pricing and availability is not currently available.


sufficient for 96 multiwell tests

shipped in

wet ice

storage temp.


General description

A solid-phase sandwich enzyme-linked immunosorbent assay (ELISA). A monoclonal capture antibody specific for the NH2 terminus of hAβ has been coated onto the multiwell strips. hAβ antigen in standards and samples binds to the capture antibody. A detection antibody specific for the hAβ 1−40 or 1−42 sequence binds the immobilized hAβ. An anti-rabbit IgG-HRP completes the sandwich. The reaction is visualized by TMB substrate, followed by the stop solution. The intensity of the yellow color is directly proportional to the concentration of hAβ in the original sample.


The ELISA can be used for in vitro quantitative determination of human native and recombinant β-amyloid 1-40 (hAβ40) protein in serum, cell culture supernatants and other biological sample with no crossreactivity with Aβ42/Aβ43.
Human β-amyloid (hAβ) ELISAs are designed for in vitro quantitative detection of native and recombinant β-amyloid in sera, cell culture supernatants and other biological samples. hAβ′s are main component of the protein deposits in neurofibrillary tangles, neuritic plaques and neuropil threads in the cerebral cortex of Alzheimer′s Disease (AD) and Down′s Syndrome. The antibodies used in these kits selectively differentiate between Aβ40 and Aβ42/Aβ43.

Features and Benefits

The assay is a sensitive (10 pg/mL), and specific alternative to immunoblotting or RIA.

Safety Statement



UN 3316 9/PG 3

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.